Our Mission
Our mission is to guide public health decision-making in order to improve population health through an evidence-based epidemiological approach, defined according to the following four areas:
1. Infectious diseases: from the laboratory to the patient's bedside and public health
2. Social and environmental health inequalities
3. Evaluation of treatments and care strategies
(PEPITES – CLEPIVIR - THERAVIR – ESSMA - FORECAST)
4. Methodological developments in causal inference and complex systems
1. Infectious diseases: from the laboratory to the patient's bedside and public health.
We assess how the environment, behaviors, and interventions, whether medicinal or not, shape exposure to infectious and zoonotic agents and mitigate their public health burden (SUMO – THERAVIR - CLEPIVIR).
2. Social and environmental health inequalities.
We use observational and interventional approaches, including participatory research, the use of embedded sensors, and mixed quantitative and qualitative methods to study the social and environmental determinants of mental and physical health and risky practices or behaviors (NEMESIS – ESSMA).
3. Evaluation of treatments and care strategies.
We evaluate the effectiveness and tolerance of treatments in real life, as well as care strategies, including complex multimodal interventions, implemented to improve patient care and population health (PEPITES – CLEPIVIR – THERAVIR – ESSMA – FORECAST).
4. Methodological developments in causal inference and complex systems.
We develop methods to estimate causal effects, identify the root causes of incidents, and make causal discoveries from observational data; and complex systems approaches to study how heterogeneities in human behavior over time and space, social networks, and mobility influence the transmission of infectious diseases (SUMO – CIPHOD - PEPITES).